Despite being highly preventable, cervical cancer is the fourth most common cancer and
cause of cancer death in women globally. In low‐income countries, cervical cancer is often …

Human papillomavirus (HPV), a common sexually transmitted virus infecting mucosal or
cutaneous stratified epithelia, is implicated in the rising of associated cancers worldwide …

Human papillomaviruses (HPVs) are ubiquitous, well adapted to their host and cleverly
sequestered away from immune responses. HPV infections can be productive, subclinical or …

Human papillomavirus (HPV) vaccination prevents cervical, head and neck, and anogenital
cancers. However, global HPV vaccine coverage falls short of global targets and has seen …

Cervical human papillomavirus (HPV) infection may increase HIV risk. Since other genital
infections enhance HIV susceptibility by inducing inflammation, we assessed the impact of …

A genital inflammatory profile contributes to the high risk of HIV acquisition in African
women. STIs and bacterial vaginosis are poorly managed in Africa and other developing …

The etiological role of human papillomavirus (HPV) in anogenital tract and head and neck
cancers is well established. However, only a low percentage of HPV-positive women …

An estimated 499 million curable sexually transmitted infections (STIs; gonorrhea,
chlamydia, syphilis, and trichomoniasis) occurred globally in 2008. In addition, well over 500 …

The Global Plan towards the elimination of new HIV infections among children by 2015 and
keeping their mothers alive (Global Plan) has ensured that more infants in high-HIV burden …

The role of sex hormones in regulating immune responses in the female genital tract has
been recognized for decades. More recently, it has become increasingly clear that sex …